serplulimab
fosun pharmaceuticals
['serplulimab', 'sclc']
#asco22 professor ying cheng presents results from astrum-005 of chemotherapy +/- serplulimab (anti-pd-1) for #sclc. mostly enrolled in china and eastern europe. fairly high screen failure rate. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him